Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis

被引:0
|
作者
Aikaterini Skorda
Anna Røssberg Lauridsen
Chengnan Wu
Jinrong Huang
Monika Mrackova
Nuggi Ingholt Winther
Vanessa Jank
Zsofia Sztupinszki
Robert Strauss
Mesut Bilgin
Kenji Maeda
Bin Liu
Yonglun Luo
Marja Jäättelä
Tuula Kallunki
机构
[1] Danish Cancer Institute,Cancer Invasion and Resistance
[2] Aarhus University,Department of Biomedicine
[3] Danish Cancer Institute,Translational Cancer Genomics
[4] Danish Cancer Institute,Genome Integrity Group
[5] Danish Cancer Institute,Lipidomics Core Facility
[6] Danish Cancer Institute,Cell Death and Metabolism, Center for Autophagy, Recycling and Disease
[7] Aarhus University Hospital,Steno Diabetes Center Aarhus
[8] University of Copenhagen,Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences
[9] University of Copenhagen,Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences
来源
Oncogene | 2023年 / 42卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cancer cells are dependent on cholesterol, and they possess strictly controlled cholesterol homeostasis mechanisms. These allow them to smoothly switch between cholesterol synthesis and uptake to fulfill their needs and to adapt environmental changes. Here we describe a mechanism of how cancer cells employ oncogenic growth factor signaling to promote uptake and utilization of extracellular cholesterol via Myeloid Zinc Finger 1 (MZF1)-mediated Niemann Pick C1 (NPC1) expression and upregulated macropinocytosis. Expression of p95ErbB2, highly oncogenic, standard-treatment resistant form of ErbB2 mobilizes lysosomes and activates EGFR, invasion and macropinocytosis. This is connected to a metabolic shift from cholesterol synthesis to uptake due to macropinocytosis-enabled flow of extracellular cholesterol. NPC1 increase facilitates extracellular cholesterol uptake and is necessary for the invasion of ErbB2 expressing breast cancer spheroids and ovarian cancer organoids, indicating a regulatory role for NPC1 in the process. The ability to obtain cholesterol as a byproduct of increased macropinocytosis allows cancer cells to direct the resources needed for the energy-consuming cholesterol synthesis towards other activities such as invasion. These results demonstrate that macropinocytosis is not only an alternative energy source for cancer cells but also an efficient way to provide building material, such as cholesterol, for its macromolecules and membranes.
引用
收藏
页码:2495 / 2506
页数:11
相关论文
共 50 条
  • [1] Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis
    Skorda, Aikaterini
    Lauridsen, Anna Rossberg
    Wu, Chengnan
    Huang, Jinrong
    Mrackova, Monika
    Winther, Nuggi Ingholt
    Jank, Vanessa
    Sztupinszki, Zsofia
    Strauss, Robert
    Bilgin, Mesut
    Maeda, Kenji
    Liu, Bin
    Luo, Yonglun
    Jaattela, Marja
    Kallunki, Tuula
    ONCOGENE, 2023, 42 (33) : 2495 - 2506
  • [2] Mutations in NPC1 and cholesterol metabolism in the brain
    Dietschy, John M.
    FASEB JOURNAL, 2009, 23
  • [3] Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease
    Kagedal, Katarina
    Kim, Woojin Scott
    Appelqvist, Hanna
    Chan, Sharon
    Cheng, Danni
    Agholme, Lotta
    Barnham, Kevin
    McCann, Heather
    Halliday, Glenda
    Garner, Brett
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2010, 1801 (08): : 831 - 838
  • [4] NPC1 links cholesterol trafficking to microglial morphology via the gastrosome
    Zareba, Joanna
    Cattaneo, Elena F.
    Villani, Ambra
    Othman, Alaa
    Streb, Sebastian
    Peri, Francesca
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [5] Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R
    Filippakis, Harilaos
    Alesi, Nicola
    Ogorek, Barbara
    Nijmeh, Julie
    Khabibullin, Damir
    Gutierrez, Catherine
    Valvezan, Alexander J.
    Cunningham, James
    Priolo, Carmen
    Henske, Elizabeth P.
    ONCOTARGET, 2017, 8 (24) : 38099 - 38112
  • [6] Liver X receptor activation enhances cholesterol loss from the brain, decreases neuroinflammation, and increases survival of the NPC1 mouse
    Repa, Joyce J.
    Li, Hao
    Frank-Cannon, Tamy C.
    Valasek, Mark A.
    Turley, Stephen D.
    Tansey, Malu G.
    Dietschy, John M.
    JOURNAL OF NEUROSCIENCE, 2007, 27 (52): : 14470 - 14480
  • [7] MISFOLDING AND DEGRADATION OF THE KEY LYSOSOMAL CHOLESTEROL TRANSPORTER NPC1 LEADS TO DISRUPTION OF ACINAR CELL CHOLESTEROL METABOLISM AND WORSENS DISEASE SEVERITY IN EXPERIMENTAL AND HUMAN PANCREATITIS
    Mareninova, Olga A.
    Chang, Alex G.
    Little, Chloe
    Malpica, Sebastian Hernandez
    Mamita, Rami
    Shalbueva, Natalia
    Gukovsky, Ilya
    Gukovskaya, Anna
    GASTROENTEROLOGY, 2024, 166 (05) : S1049 - S1050
  • [8] FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts
    Newton, Jason
    Hait, Nitai C.
    Maceyka, Michael
    Colaco, Alexandria
    Maczis, Melissa
    Wassif, Christopher A.
    Cougnoux, Antony
    Porter, Forbes D.
    Milstien, Sheldon
    Platt, Nicholas
    Platt, Frances M.
    Spiegel, Sarah
    FASEB JOURNAL, 2017, 31 (04): : 1719 - 1730
  • [9] Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1
    van der Veen, JN
    Kruit, JK
    Havinga, R
    Baller, JFW
    Chimini, G
    Lestavel, S
    Staels, B
    Groot, PHE
    Groen, AK
    Kuipers, F
    JOURNAL OF LIPID RESEARCH, 2005, 46 (03) : 526 - 534
  • [10] Gut microbiota alter cholesterol metabolism and regulate NPC1L1 by inducing the expression of Cyp7a1
    Zhong, Chunyan
    Yu, Liqing
    Sun, Weiwei
    Wei, Hong
    Zeng, Benhua
    Song, Zhiyuan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C69 - C69